Immunomedics, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$240Kgeneral payments (2019-2025)
$525research payments (2019-2025)
411clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Jay Mason | Reno, NV | Cardiovascular Disease | $14,168.33 |
| Rebecca Moroose | Orlando, FL | Medical Oncology | $13,772.14 |
| Virginia Kaklamani | San Antonio, TX | Medical Oncology | $10,000.00 |
| Robert Weaver | Tampa, FL | Medical Oncology | $7,238.22 |
| Lori Goldstein | Philadelphia, PA | Medical Oncology | $5,637.50 |
| Elyse Lower | Cincinnati, OH | Medical Oncology | $5,359.70 |
| Ingrid Mayer | Nashville, TN | Medical Oncology | $5,225.00 |
| Guru Sonpavde | Orlando, FL | Medical Oncology | $5,200.00 |
| Rita Nanda | Chicago, IL | Hematology & Oncology | $5,150.00 |
| John Park | San Francisco, CA | Medical Oncology | $4,525.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.